financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer
Mar 20, 2025 6:23 AM

08:46 AM EDT, 03/20/2025 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) announced Thursday that an external data safety monitoring board has completed its second safety data review and recommended that the company continue "without any modifications" its current pivotal phase 3 trial of Bria-IMT plus an immune checkpoint inhibitor in metastatic breast cancer.

The company added that it is currently conducting the phase 3 trial under the US Food and Drug Administration's fast-track designation.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Caesars Entertainment Opens Caesars Virginia Resort, Casino
Caesars Entertainment Opens Caesars Virginia Resort, Casino
Dec 18, 2024
04:22 AM EST, 12/18/2024 (MT Newswires) -- Caesars Entertainment ( CZR ) said late Tuesday it has opened its Caesars Virginia resort and casino in the city of Danville. The 587,000-square-foot resort includes gambling space and a 320-room hotel, among other facilities. ...
 Affirm Prices Upsized $800 Million Offering of 2029 Convertible Notes
Affirm Prices Upsized $800 Million Offering of 2029 Convertible Notes
Dec 18, 2024
04:28 AM EST, 12/18/2024 (MT Newswires) -- Affirm (AFRM) said late Tuesday it priced the private offering of $800 million of its 0.75% convertible senior notes due 2029, up from the initial size of $750 million. The initial conversion rate of the notes will be 9.8992 class A common shares per $1,000 in principal amount of notes, which is equivalent...
 Starwood Property Trust Prices $500 Million Private Notes Offering
Starwood Property Trust Prices $500 Million Private Notes Offering
Dec 18, 2024
04:26 AM EST, 12/18/2024 (MT Newswires) -- Starwood Property Trust ( STWD ) said late Tuesday it priced a private offering of $500 million of its 6.5% unsecured senior notes due 2030 at 100% of the principal amount. The offering was upsized from $400 million and is expected to settle on Dec. 27. The company said it plans to use...
 Novo Nordisk's Ozempic faces EU review for potential eye disease connection
Novo Nordisk's Ozempic faces EU review for potential eye disease connection
Dec 18, 2024
COPENHAGEN, Dec 18 (Reuters) - The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's popular diabetes drug Ozempic to a rare eye disease. The studies published earlier this week had found Ozempic significantly increases the risk of type 2 diabetes patients developing NAION (non-arteritic anterior ischemic optic neuropathy), more than doubling the...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved